Journal article icon

Journal article

Increased cortical neuronal responses to NMDA and improved attentional set-shifting performance in rats following prebiotic (B-GOS®) ingestion

Abstract:
We have previously shown that prebiotics (dietary fibres that augment the growth of indigenous beneficial gut bacteria) such as BimunoTM galacto-oligosaccharides (B-GOS®), increased N-methyl-D-aspartate (NMDA) receptor levels in the rat brain. The current investigation examined the functional correlates of these changes in B-GOS®-fed rats by measuring cortical neuronal responses to NMDA using in vivo NMDA micro-iontophoresis electrophysiology, and performance in the attentional set-shifting task. Adult male rats were supplemented with B-GOS® in the drinking water 3 weeks prior to in vivo iontophoresis or behavioural testing. Cortical neuronal responses to NMDA iontophoresis, were greater (+30%) in B-GOS® administered rats compared to non-supplemented controls. The intake of B-GOS® also partially hindered the reduction of NMDA responses by the glycine site antagonist, HA-966. In the attentional set-shifting task, B-GOS® -fed rats shifted from an intra-dimensional to an extra-dimensional set in fewer trials than controls, thereby indicating greater cognitive flexibility. An initial exploration into the mechanisms revealed that rats ingesting B-GOS® had increased levels of plasma acetate, and cortical GluN2B subunits and Acetyl Co-A Carboxylase mRNA. These changes were also observed in rats fed daily for 3 weeks with glyceryl triacetate, though unlike B-GOS®, cortical histone deacetylase (HDAC1, HDAC2) mRNAs were also increased which suggested an additional epigenetic action of direct acetate supplementation. Our data demonstrate that a pro-cognitive effect of B-GOS® intake in rats is associated with an increase in cortical NMDA receptor function, but the role of circulating acetate derived from gut bacterial fermentation of this prebiotic requires further investigation.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1016/j.euroneuro.2017.11.001

Authors


More from this funder
Grant:
Industrial Partnership Award (Principal Investigator, Dr Burnet
Grant Code: BB/I006311/1


Publisher:
Elsevier
Journal:
European Neuropsychopharmacology More from this journal
Volume:
28
Issue:
1
Pages:
211-224
Publication date:
2017-11-22
Acceptance date:
2017-11-02
DOI:
ISSN:
0924-977X


Keywords:
Pubs id:
pubs:742558
UUID:
uuid:3e4df25b-1aa4-4c33-acb7-e5f8279b2b50
Local pid:
pubs:742558
Source identifiers:
742558
Deposit date:
2017-11-03
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP